Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new collaborative study involving DPAG's Wilson and Goberdhan Groups and the Nuffield Department of Surgical Sciences (NDS) has revealed surprising parallels between ‘prostate’ cells in flies and cancer patients.

Striking image

A new article from the collaborating groups of Clive Wilson and Deborah Goberdhan in DPAG and Freddie Hamdy in the Nuffield Department of Surgical Sciences is shedding new light on the mechanisms that lead to lethal forms of prostate cancer. Men with advanced prostate cancer are routinely treated with drugs that block the production of the steroid testosterone, which inhibits tumour growth. But within a couple of years, hormone-independent tumour cells emerge, which often still require the testosterone receptor to grow and this will lead to the death of the patient. Such pathological hormone-independent receptor signalling was thought to be unique to cancer cells.

DPAG's Aaron Leiblich, Josephine Hellberg and Aashika Sekar have now shown that prostate-like cells in the fruit fly also require a steroid hormone to grow; this hormone-dependent signalling stimulates secretion of proteins into the seminal fluid to promote fertility, just like the human prostate. However, when male flies mate, the steroid receptor switches to a hormone-independent mechanism when males mate. This stimulates more growth in these cells and drives more secretion, rapidly replacing what has been lost during mating. As in prostate cancer, this switch to hormone-independence involves the activation of proteins that stimulate cells to replicate their DNA.

"When Aaron Leiblich, a surgeon in my lab, first showed that steroids are required for growth of the fly prostate, we set out to genetically manipulate the cells to mirror the pathological switch to hormone-independent growth found in cancer patients," Clive Wilson recalls. "It was a big surprise to finally discover that this switch is a normal physiological process linked to mating."

Aashika Sekar, a third year DPhil student who is continuing the study, added: "We’ve already identified other genes that seem to only control the hormone-independent form of steroid receptor signalling in flies. These genes have also been implicated in prostate cancer, so if we can work out how to inhibit their action in flies, perhaps this will give us new ideas for blocking the lethal form of prostate cancer growth."

 

The full paper "Mating induces switch from hormone-dependent to hormone-independent steroid receptor-mediated growth in Drosophila secondary cells" is available to read in PLOS Biology.

Image Legend (above): The prostate-like cells in the fly male accessory gland that switch to steroid-independent growth (marked by red staining) have a higher turnover of secretory compartments (shown in green) than their neighbours

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.

Key exosome subtype in cancer progression identified

Collaborative work from DPAG and Oncology researchers has revealed a potential new pathway to block the production of a specific group of exosomes made in the cell’s recycling system that can promote the growth of cancerous tumours.

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.